Angela Hildebrand has been named the general manager of Skin Ceuticals USA by L’Oréal USA. In February 2022, Amy Sloan was promoted to general manager; she now serves as senior vice president of business strategy and expansion.
According to Tina Fair, President of the L’Oréal Dermatological Beauty Division in North America, “Angela and Amy’s leadership are poised to take Skin Ceuticals to new heights with their collective knowledge, expertise, and commitment to excellence.”
Twenty years of aesthetic industry experience are brought to the General Manager position by Angela Hildebrand. Most recently, she co-led strategy on medical acceleration projects with Tina Fair at L’Oréal Dermatological Beauty as the General Manager of Medical Commercial Strategy. Prior to that, she oversaw the U.S. during her eight years as Skin Ceuticals’ SVP of Sales.
With Tina, Amy, and the rest of the team, we will definitely take our brand and the whole medical skincare market to the next level as Skin Ceuticals continues to expand tremendously and our distribution network grows at such a quick rate, according to Hildebrand. Amy Sloan will work closely with Hildebrand in her new position to concentrate on strategic development initiatives and keep leading of the Marketing, Retail, Digital/E-retail, and Advocacy & Influence teams to sustain momentum with product innovation, services, business models, and partnerships, as well as consumer experience across all channels.
“This next chapter in my Skin Ceuticals profession is an exciting one,”
With Angela in charge, we’ll work together to guarantee that our doctors, their patients, and all customers have the finest omnichannel experience with our cutting-edge, scientifically-backed skincare.
In the US, SkinCeuticals claims to be the market leader in medical aesthetic skincare. Over 6,000 medical locations countrywide carry the brand.